Marco Venturini

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Lunardi Gianluigi; Armirotti Andrea; Nicodemo Maurizio; Cavallini Lucia; Damonte Gianluca; Vannozzi Maria O; Venturini Marco
Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: a case series.
Del Mastro L; Dozin B; Aitini E; Catzeddu T; Baldini E; Contu A; Durando A; Danese S; Cavazzini G; Canavese G; Bruzzi P; Pronzato P; Venturini M;
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.
Del Mastro Lucia; Clavarezza Matteo; Venturini Marco
Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitors.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Marco Venturini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lunardi Gianluigi; Armirotti Andrea; Nicodemo Maurizio; Cavallini Lucia; Damonte Gianluca; Vannozzi Maria O; Venturini Marco
Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: a case series.
Clinical therapeutics 2009;31(8):1812-9.
2008: Del Mastro L; Dozin B; Aitini E; Catzeddu T; Baldini E; Contu A; Durando A; Danese S; Cavazzini G; Canavese G; Bruzzi P; Pronzato P; Venturini M;
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):299-307.
2007: Del Mastro Lucia; Clavarezza Matteo; Venturini Marco
Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitors.
Cancer treatment reviews 2007;33(8):681-7.
2007: Clavarezza Matteo; Del Mastro Lucia; Pronzato Paolo; Bruzzi Paolo; Venturini Marco
Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Journal of the National Cancer Institute 2007;99(13):1050-1; author reply 1051-2.
2006: Del Mastro Lucia; Catzeddu Tiziana; Venturini Marco
Infertility and pregnancy after breast cancer: current knowledge and future perspectives.
Cancer treatment reviews 2006;32(6):417-22.
2006: Clavarezza M; Del Mastro L; Venturini M
Taxane-containing chemotherapy in the treatment of early breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii22-6.
2006: Montemurro Filippo; Donadio Michela; Clavarezza Matteo; Redana Stefania; Jacomuzzi Maria Elena; Valabrega Giorgio; Danese Saverio; Vietti-Ramus Guido; Durando Antonio; Venturini Marco; Aglietta Massimo
Outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy.
The oncologist 2006;11(4):318-24.
2006: Venturini M; Bighin C; Monfardini S; Cappuzzo F; Olmeo N; Durando A; Puglisi F; Nicoletto O; Lambiase A; Del Mastro L
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer.
Breast cancer research and treatment 2006;95(1):45-53.
2006: Del Mastro L; Catzeddu T; Boni L; Bell C; Sertoli M R; Bighin C; Clavarezza M; Testa D; Venturini M
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(1):74-8.
2005: Venturini Marco; Del Mastro Lucia; Aitini Enrico; Baldini Editta; Caroti Cinzia; Contu Antonio; Testore Franco; Brema Fulvio; Pronzato Paolo; Cavazzini Giovanna; Sertoli Mario Roberto; Canavese Giuseppe; Rosso Riccardo; Bruzzi Paolo
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
Journal of the National Cancer Institute 2005;97(23):1724-33.
2005: Del Mastro L; Bruzzi P; Nicolò G; Cavazzini G; Contu A; D'Amico M; Lavarello A; Testore F; Castagneto B; Aitini E; Perdelli L; Bighin C; Rosso R; Venturini Marco
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients.
British journal of cancer 2005;93(1):7-14.
2005: Del Mastro L; Perrone F; Repetto L; Manzione L; Zagonel V; Fratino L; Marenco D; Venturini M; Maggi E; Bighin C; Catzeddu T; Venturino A; Rosso R;
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):253-8.
2004: Conte Pier Franco; Guarneri Valentina; Bruzzi Paolo; Prochilo Tiziana; Salvadori Barbara; Bolognesi Angelo; Aldrighetti Daniela; Venturini Marco; Rosso Riccardo; Mammoliti Serafina; Carnino Flavio; Giannessi Piergiorgio; Costantini Massimo; Moyano Alfredo; Baldini Editta;
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.
Cancer 2004;101(4):704-12.
2004: Baldini E; Prochilo T; Salvadori B; Bolognesi A; Aldrighetti D; Venturini M; Rosso R; Carnino F; Gallo L; Giannessi P; Conte P F; Orlandini C; Bruzzi P
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety.
British journal of cancer 2004;91(1):45-9.
2004: Catzeddu Tiziana; Bertelli Gianfilippo; Del Mastro Lucia; Venturini Marco
Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.
Journal of surgical oncology 2004;85(3):129-32.
2003: Lunardi G; Vannozzi M O; Bighin C; Del Mastro L; Stevani I; Schettini G; Venturini M
Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1222-6.
2003: Venturini Marco; Durando Antonio; Garrone Ornella; Colozza Maria Antonietta; Contu Antonio; Stevani Ilaria; Genta Franco; Bighin Claudia; Lambiase Antonio; Del Mastro Lucia
Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.
Cancer 2003;97(5):1174-80.
2002: Bertelli G; Venturini M; Del Mastro L; Bergaglio M; Sismondi P; Biglia N; Venturini S; Porcile G; Pronzato P; Costantini M; Rosso R
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):883-8.
2002: Venturini M; Del Mastro L; Garrone O; Angiolini C; Merlano M; Bergaglio M; Tolino G; Lambiase A; Baldini A; Canavese G; Rosso R
Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):546-52.
2002: Lunardi G; Venturini M; Vannozzi M O; Tolino G; Del Mastro L; Bighin C; Schettini G; Esposito M
Influence of alternate sequences of epirubicin and docetaxel on the pharmacokinetic behaviour of both drugs in advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):280-5.
2002: Del Mastro L; Costantini M; Morasso G; Bonci F; Bergaglio M; Banducci S; Viterbori P; Conte P; Rosso R; Venturini M
Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2002;38(3):359-66.
2002: Venturini Marco; Catzeddu Tiziana
[New therapeutic prospects with capecitabin in breast carcinoma]
Tumori 2002;88(1):A1-6.
2002: Bighin Claudia; Stevani Ilaria; Venturini Marco
Herceptin in elderly patients.
Tumori 2002;88(1 Suppl 1):S37-8.
2001: Banfi A; Podestà M; Fazzuoli L; Sertoli M R; Venturini M; Santini G; Cancedda R; Quarto R
High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia.
Cancer 2001;92(9):2419-28.
2001: Venturini M; Michelotti A; Papaldo P; Del Mastro L; Bergaglio M; Lionetto R; Lunardi G; Sguotti C; Frevola L; Donati S; Rosso R; Cognetti F
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(8):1097-106.
2001: Del Mastro L; Venturini M; Viscoli C; Bergaglio M; Signorini A; Bighin C; Bertelli G; Semino C; Pietra G; Bertoglio S; Sertoli M R; Lambiase A; Rosso R; Melioli G
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):505-8.
2001: Del Mastro L; Venturini M; Lionetto R; Carnino F; Guarneri D; Gallo L; Contu A; Pronzato P; Vesentini L; Bergaglio M; Comis S; Rosso R
Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2213-21.
2001: Sanguineti G; Del Mastro L; Guenzi M; Ricci P; Cavallari M; Canavese G; Stevani I; Venturini M
Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):373-8.
2001: Morasso G; Costantini M; Viterbori P; Bonci F; Del Mastro L; Musso M; Garrone O; Venturini M
Predicting mood disorders in breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2001;37(2):216-23.
2000: Venturini M; Bighin C; Catzeddu T; Stevani I
[Adjuvant chemotherapy in breast cancer. Open questions and future developments]
Tumori 2000;86(6 Suppl 1):S11-2.
2000: Venturini M; Lunardi G; Del Mastro L; Vannozzi M O; Tolino G; Numico G; Viale M; Pastrone I; Angiolini C; Bertelli G; Straneo M; Rosso R; Esposito M
Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(10):2116-25.
2000: Michelotti A; Venturini M; Tibaldi C; Bengala C; Gallo L; Carnino F; Del Mastro L; Lionetto R; Montanaro E; Rosso R; Conte P
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients.
Breast cancer research and treatment 2000;59(2):133-9.
1999: Bertelli G; Venturini M; Bergaglio M; Gustavino C; Rosso R; Valenzano M
Progestins and the endometrium in patients receiving tamoxifen.
British journal of cancer 1999;80(7):1114.
1999: Esposito M; Venturini M; Vannozzi M O; Tolino G; Lunardi G; Garrone O; Angiolini C; Viale M; Bergaglio M; Del Mastro L; Rosso R
Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1132.
1999: Del Mastro L; Venturini M
Treatment of breast cancer.
The New England journal of medicine 1999;340(4):319-20.
1998: Venturini M; Del Mastro L
More on dose-intensity of anthracyclines in breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(4):461.
1998: Dini D; Del Mastro L; Gozza A; Lionetto R; Garrone O; Forno G; Vidili G; Bertelli G; Venturini M
The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(2):187-90.
1998: Bertelli G; Venturini M; Del Mastro L; Garrone O; Cosso M; Gustavino C; Cusimano E; Guido T; Nicolò G; Rosso R
Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients.
Breast cancer research and treatment 1998;47(1):41-6.
1997: Rosso R; Del Mastro L; Venturini M; Bergaglio M; Pasquetti W; Garrone O
[Use of erythropoietin in oncology]
Tumori 1997;83(4 Suppl 2):S26-30.
1997: Del Mastro L; Venturini M; Lionetto R; Garrone O; Melioli G; Pasquetti W; Sertoli M R; Bertelli G; Canavese G; Costantini M; Rosso R
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2715-21.
1997: Del Mastro L; Venturini M; Costantini M; Garrone O; Sertoli M R; Bertelli G; Machì A M; Rosso R
Paradoxical effect of cytotoxic chemotherapy on anemia in cancer patients with beta-thalassemia minor.
Journal of the National Cancer Institute 1997;89(6):455-6.
1996: Venturini M; Michelotti A; Del Mastro L; Gallo L; Carnino F; Garrone O; Tibaldi C; Molea N; Bellina R C; Pronzato P; Cyrus P; Vinke J; Testore F; Guelfi M; Lionetto R; Bruzzi P; Conte P F; Rosso R
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(12):3112-20.
1996: Ardizzoni A; Pennucci M C; Danova M; Viscoli C; Mariani G L; Giorgi G; Venturini M; Mereu C; Scolaro T; Rosso R
Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.
British journal of cancer 1996;74(7):1141-7.
1996: Conte P F; Baldini E; Gardin G; Pronzato P; Amadori D; Carnino F; Monzeglio C; Gentilini P; Gallotti P; DeMicheli R; Venturini M; Rubagotti A; Rosso R
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):487-90.
1996: Venturini M; Mastro L D; Garrone O; Bergaglio M; Rosso R
[Mobilization of peripheral blood stem cells with conventional chemotherapy]
Tumori 1996;82(2 Suppl):S14-8.
1996: Venturini M; Bruzzi P; Del Mastro L; Garrone O; Bertelli G; Guelfi M; Pastorino S; Rosso R; Sertoli M R
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):764-73.
1996: Venturini M; Del Mastro L; Testore F; Danova M; Garrone O; Lanfranco C; Latini F; Sertoli M R; Lionetto R; Queirolo P; Ardizzoni A; Rosso R
Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer.
Cancer chemotherapy and pharmacology 1996;38(6):487-94.
1995: Bertelli G; Gozza A; Forno G B; Vidili M G; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2851-5.
1995: Sertoli M R; Bruzzi P; Pronzato P; Queirolo P; Amoroso D; Del Mastro L; Venturini M; Vigani A; Bertelli G; Campora E
Randomized cooperative study of perioperative chemotherapy in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2712-21.
1995: Del Mastro L; Venturini M; Giannessi P G; Vigani A; Garrone O; Carnino F; Russo P; Galletti P; Rosso R; Conte P F
Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility study.
Anticancer research 1995;15(5B):2207-12.
1994: Venturini M; Del Mastro L; Melioli G; Balleari E; Garrone O; Pasquetti W; Bason C; Ghio R; Bruzzi P; Rosso R
Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy.
Cancer 1994;74(8):2300-6.
1994: Noviello E; Cosimi A; Casartelli G L; Melioli G; Taverniti G; Parodi S; Pistoia V; Venturini M; Russo P
Effect of granulocyte-macrophage colony-stimulating factor on growth of a xenotransplanted human ovarian cancer cell line IGROV-1 in nude mice.
In vivo (Athens, Greece) 1994;8(2):207-13.
1994: Ardizzoni A; Venturini M; Sertoli M R; Giannessi P G; Brema F; Danova M; Testore F; Mariani G L; Pennucci M C; Queirolo P
Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer.
British journal of cancer 1994;69(2):385-91.
1994: Del Mastro L; Garrone O; Guenzi M; Cafiero F; Nicolò G; Rosso R; Venturini M
Angiosarcoma of the residual breast after conservative surgery and radiotherapy for primary carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(2):163-5.
1994: Bertelli G; Dini D; Forno G B; Gozza A; Silvestro S; Venturini M; Rosso R; Pronzato P
Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results.
Journal of cancer research and clinical oncology 1994;120(8):505-6.
1994: Del Mastro L; Garrone O; Sertoli M R; Canavese G; Catturich A; Guenzi M; Rosso R; Venturini M
A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(5):606-10.
1993: Venturini M; Del Mastro L; Ardizzoni A; Sertoli M R; Mariani G L; Pennucci M C; Garrone O; Silvestro S; Addamo G F; Queirolo P
High dose intensity chemotherapy without bone marrow support: role of granulocyte-macrophage colony-stimulating factor.
Annals of the New York Academy of Sciences 1993;698():389-97.
1993: Garrone O; Del Mastro L; Mariani G L; Ardizzoni A; Venturini M; Rosso R
[Feasibility of a cyclophosphamide methotrexate and 5-fluorouracil regime intravenously administered with and without granulocyte-colony stimulating factor in surgically treated breast carcinoma]
Minerva medica 1993;84(9):467-72.
1993: Bertelli G; Dini D; Forno G; Gozza A; Venturini M; Ballella G; Rosso R
Dimethylsulphoxide and cooling after extravasation of antitumour agents.
Lancet 1993;341(8852):1098-9.
1993: Valenti M; Cimoli G; Parodi S; Mariani G L; Venturini M; Conte P; Russo P
Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implications.
European journal of cancer (Oxford, England : 1990) 1993;29A(8):1157-61.
1993: Ardizzoni A; Venturini M; Crinò L; Sertoli M R; Bruzzi P; Pennucci M C; Mariani G L; Garrone O; Bracarda S; Rosso R
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(5):687-92.
1992: Bertelli G; Venturini M; Forno G; Macchiavello F; Dini D
An analysis of prognostic factors in response to conservative treatment of postmastectomy lymphedema.
Surgery, gynecology & obstetrics 1992;175(5):455-60.
1992: Orengo G; Noviello E; Cimoli G; Pagnan G; Parodi S; Venturini M; Conte P; Schenone F; Conzi G; Russo P
Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.
Japanese journal of cancer research : Gann 1992;83(11):1132-6.
1992: Campora E; Pronzato P; Amoroso D; Bertelli G F; Venturini M; Baldini E; Brunetti I; Sertoli M R; Conte P; Rosso R
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF.
Anticancer research 1992;12(5):1555-8.
1992: Cimoli G; Valenti M; Venturini M; Conte P; Russo P
Augmentation of antineoplastic effects by the combination of recombinant human tumor necrosis factor and mitoxantrone on primary culture of human ovarian cancer cells.
Anticancer research 1992;12(5):1411-4.
1992: Russo P; Parodi S; Billi G; Oliva C; Venturini M; Noviello E; Conte P
Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines.
Japanese journal of cancer research : Gann 1992;83(7):684-7.
1992: Rosso R; Sertoli M R; Queirolo P; Sanguineti O; Barzacchi M C; Mariani G L; Miglio L; Venturini M; Toma S
An outpatient phase I study of a subcutaneous interleukin-2 and intramuscular alpha-2a-interferon combination in advanced malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(7):559-63.
1992: Nobile M T; Rosso R; Sertoli M R; Rubagotti A; Vidili M G; Guglielmi A; Venturini M; Canobbio L; Fassio T; Gallo L
Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1823-7.
1991: Mariani G L; Pennucci M C; Addamo G; Venturini M; Ardizzoni A; Rosso R
A pilot study of mitomycin, ifosfamide and cisplatin as outpatient combination chemotherapy for advanced non-small cell lung cancer.
Tumori 1991;77(6):511-3.
1991: Cimoli G; Russo P; Billi G; Mariani G L; Rovini E; Venturini M
Human granulocyte-macrophage colony-stimulating factor is a growth factor active on human ovarian cancer cells.
Japanese journal of cancer research : Gann 1991;82(11):1196-8.
1991: Bertelli G; Venturini M; Forno G; Macchiavello F; Dini D
Conservative treatment of postmastectomy lymphedema: a controlled, randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(8):575-8.
1991: Nobile M T; Vidili M G; Sertoli M R; Venturini M; Simoni G; Civalleri D; Bertoglio S; Percivale P; Torelli P; Spagliardi E
Intrahepatic epidoxorubicin in metastatic and primary liver tumours: a phase II study.
Anticancer research 1991;11(2):861-4.
1991: Dini D; Venturini M; Forno G; Bertelli G; Grandi G
Irrigation for colostomized cancer patients: a rational approach.
International journal of colorectal disease 1991;6(1):9-11.
1990: Venturini M; Bertelli G; Forno G; Grandi G; Dini D
Colostomy irrigation in the elderly. Effective recovery regardless of age.
Diseases of the colon and rectum 1990;33(12):1031-3.
1989: Nobile M T; Vidili M G; Benasso M; Venturini M; Tedeschi M; Zunino F; Rosso R
A preliminary clinical study of cyclophosphamide with reduced glutathione as uroprotector.
Tumori 1989;75(3):257-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Marco Venturini

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Marco Venturini (preview)

All Publications